Following the completion of its $ 20 m funding round , Discovery Health has partnered with Aptar Pharma to expand its digital medicine software to a larger range of medical devices . Aptar is one of the largest manufacturers of drug - delivery devices and raised $ 20 m . Aptar first signed an agreement with Propeller in 2016 to develop a metered dose inhaler for asthma and respiratory diseases with embedded sensors. It has now raised $ 65.5 m and supports young people with its US regulator - approved digital asthma management programmes . Digital therapies are gaining traction with both healthcare providers and pharmaceutical companies , providing a personalised and cheaper alternative to increasingly expensive drugs .
Following the completion of its $ 20 m funding round , Discovery Health has partnered with Aptar Pharma to expand its digital medicine software to a larger range of medical devices . Aptar is one of the largest manufacturers of drug - delivery devices and raised $ 20 m . It has now raised $ 65.5 m and supports young people with its US regulator - approved digital asthma management programmes . Digital therapies are gaining traction with both healthcare providers and pharmaceutical companies , providing a personalised and cheaper alternative to increasingly expensive drugs .